Veteran private-equity investor focused on growth-stage technology and healthcare companies, specializing in buyouts, operational value creation and go-to-market scaling. Brandon Smith brings over a decade of cross-border investing and operating experience, having led platform investments, add-on acquisitions and board oversight across SaaS, digital health and enterprise software. Deeply involved in portfolio transformation, capital allocation and senior management recruitment, he is known for thesis-driven sourcing and exit execution. Investment remit typically targets $50m–$300m enterprise value companies and institutional LP relationships, with an emphasis on revenue growth, margin expansion and strategic M&A.
Veteran private-equity investor focused on growth-stage technology and healthcare companies, specializing in buyouts, operational value creation and go-to-market scaling. Brandon Smith brings over a decade of cross-border investing and operating experience, having led platform investments, add-on acquisitions and board oversight across SaaS, digital health and enterprise software. Deeply involved in portfolio transformation, capital allocation and senior management recruitment, he is known for thesis-driven sourcing and exit execution. Investment remit typically targets $50m–$300m enterprise value companies and institutional LP relationships, with an emphasis on revenue growth, margin expansion and strategic M&A.
Focuses on growth-stage technology and healthcare buyouts, prioritizing scalable SaaS, digital health, and enterprise software businesses where operational interventions and go-to-market scaling can unlock value. Applies a thesis-driven sourcing model, targets $50m–$300m enterprise value platforms, and pursues add-on M&A to accelerate consolidation. Capital allocation balances minority growth rounds with control buyouts to drive revenue growth and margin expansion over a 3–7 year exit horizon. Risk disciplined through active board oversight, management recruitment, and performance-linked operational KPIs to de-risk exits for institutional LPs.
Focuses on growth-stage technology and healthcare buyouts, prioritizing scalable SaaS, digital health, and enterprise software businesses where operational interventions and go-to-market scaling can unlock value. Applies a thesis-driven sourcing model, targets $50m–$300m enterprise value platforms, and pursues add-on M&A to accelerate consolidation. Capital allocation balances minority growth rounds with control buyouts to drive revenue growth and margin expansion over a 3–7 year exit horizon. Risk disciplined through active board oversight, management recruitment, and performance-linked operational KPIs to de-risk exits for institutional LPs.
| Trades 379 | Longs Won 306/379 80% | Profit Factor 49.05 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $489,589.41 |
| Average Win $152,140.52 | Best Trade (Oct 14) $7.47M | Sharpe Ratio -11.53 |
| Average Loss -$13,001.82 | Worst Trade (Oct 14) -$70,122 | Z-Score 20.48 (100%) |
| Commissions $0 | Avg. Trade Length 11m 3w 1d | Expectancy $120,332.1 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 15,625 | 14,063 | 12,500 | 10,938 | 9,375 | 7,813 | 6,250 | 4,688 | 3,125 | 1,563 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 8,101 | $2.03M | $2.77M | - | $743,610.14 | 36.63% | -0.173% |
ADBE Adobe Inc. | 1,055 | $248,836.98 | $262,684.34 | - | $13,847.36 | 5.56% | +3.453% |
ADI Analog Devices, Inc. | 703 | $223,652 | $283,983.88 | - | $60,331.88 | 26.98% | +0.097% |
AFBI Affinity Bancshares Inc. | 41,000 | $912,660 | $943,000 | - | $30,340 | 3.32% | 0.0 |
AFL Aflac Inc. | 2,478 | $256,324.76 | $292,688.97 | - | $36,364.21 | 14.19% | -0.08% |
AKRE Akre Focus ETF | 5,462 | $338,826.08 | $315,020.85 | - | -$23,805.23 | -7.03% | +3.583% |
AMGN Amgen Inc. | 1,245 | $324,496.61 | $546,850.06 | - | $222,353.45 | 68.52% | +3.081% |
APD Air Products and Chemicals, Inc. | 2,275 | $659,841.19 | $673,525.12 | - | $13,683.93 | 2.07% | +1.205% |
ASML ASML Holding N.V. New York Registry Shares | 250 | $200,348 | $413,458.27 | - | $213,110.27 | 106.37% | +0.232% |
AVUV Avantis U.S. Small Cap Value ETF | 38,944 | $3.75M | $4.68M | - | $933,525.82 | 24.9% | +0.885% |
BAC Bank of America Corporation | 5,825 | $256,009 | $301,269 | - | $45,260 | 17.68% | +0.642% |
BHLB Berkshire Hills Bancorp Inc | 22,100 | $663,000 | $663,000 | - | - | - | 0.0 |
BKNG Booking Holdings Inc. | 1,625 | $318,848.22 | $270,042.5 | - | -$48,805.72 | -15.31% | +3.423% |
BLK BlackRock, Inc. | 660 | $663,892.91 | $738,794.1 | - | $74,901.19 | 11.28% | +4.246% |
BRK-B Berkshire Hathaway Inc. | 1,300 | $602,224 | $685,763 | - | $83,539 | 13.87% | +0.22% |
BUSE First Busey Corporation | 10,000 | $252,700 | $292,300 | - | $39,600 | 15.67% | +0.967% |
C Citigroup Inc. | 16,100 | $1.83M | $1.98M | - | $156,009 | 8.54% | +0.679% |
COR Cencora, Inc. | 994 | $223,332 | $338,675.68 | - | $115,343.68 | 51.65% | +1.353% |
COST Costco Wholesale Corporation | 253 | $231,816.21 | $248,334.68 | - | $16,518.47 | 7.13% | -0.045% |
CSCO Cisco Systems, Inc. | 16,081 | $952,002.29 | $1.76M | - | $809,992.88 | 85.08% | -3.581% |